Outcome of therapy for patients evaluated over 24 weeks. Information regarding starting dose was missing for 3 patients, and there was insufficient follow-up data for the dose increase and no dose change (noted now with asterisk) to determine the percentage of patients achieving National Cholesterol Education Program Adult Treatment Panel II (NCEP) low-density lipoprotein cholesterol (LDL-C) goal in this group of 37 patients at the end of 24 weeks.